Baxter Healthcare Corporation Vasopressin, in 0.9% Sodium Chloride Injection recall: CGMP Deviations
CGMP Deviations
The hazard: Sterility or particulate concern
This recall is about sterility assurance. It does not mean every unit is contaminated — it means the manufacturer cannot demonstrate that none of them is.
What the notice says: CGMP Deviations
Why it matters: The product was made or packaged in conditions that cannot assure sterility, or visible particles were found in it. For anything injected, infused or used in the eye, that is a direct route for contamination into the body.
Symptoms and when to call a doctor
Watch for fever, chills, pain, redness, swelling or discharge at an injection site, and for a red, painful or suddenly blurred eye after using an eye product. Any of these needs same-day medical attention. Do not wait to see whether it settles, and tell the clinician which product and lot you used so it can be reported against the recall.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0819-2026
- Published
- September 9, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Baxter Healthcare Corporation
- Product type
- Prescription & OTC drugs
- Units affected
- N/A
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot # NC185448, Exp Date: 8/31/2027; Lot # NC192910, Exp Date: 4/30/2028; Lot # NC195218, Exp Date: 6/30/2028.
Products covered by this recall
Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dose Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-9647-12.
Check your product
The notice names 10 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- NC185448
- NC192910
- NC195218
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 31
- 2027
- 30
- 2028
- 2028. — N
NDC number
On the carton and again on the bottle or blister label.
- 0338-9647-12
Package size
Match the net weight or the piece count on the front of the pack.
- 100 mL
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Sterility
Baxter Healthcare Corporation — This recall is about sterility assurance. It does not mean every unit is contaminated — it means the manufacturer cannot demonstrate that none of them is.
- Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
- If you are a clinic or pharmacy, quarantine the stock and work it through your usual recall log.
- Report any infection or reaction you think the product caused to FDA MedWatch.
- Do not use a vial or syringe with visible particles, cloudiness or discolouration, whether or not it is on the recall list.
Refunds and replacements
With medicines, a replacement supply matters more than cash, and that is what pharmacies are set up to provide.
- Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
- For a mail-order or online pharmacy, use the recall line listed on this page rather than the general support queue.
- If the recall voided a fill you had already paid for, your insurer will normally authorise a replacement ahead of schedule. Quote the recall number.
- If you paid out of pocket, ask for a refund of the co-pay or purchase price and keep the receipt the pharmacy issues.
Company contact: Baxter Healthcare Corporation — 1 Baxter Pkwy, Deerfield, IL, 60015-4625
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Baxter Healthcare Corporation prescription & otc drugs recalled?
CGMP Deviations CGMP Deviations
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code NC185448, NC192910, NC195218; best-by date 31 or 2027. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
Can I get my money back?
Ask the dispensing pharmacy for a like-for-like replacement from an unaffected lot. This is the fastest route and usually costs nothing.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 25 days ago
Baxter Healthcare Corporation PRO+ 40" MRS Surface recall: There is an error in the product description on the Unique Device
There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the…
-
Class II · 25 days ago
Baxter Healthcare Corporation Brand Name: Volara System Product Name: Volara, HC recall: Contamination within the release test equipment flow path could have affected
Contamination within the release test equipment flow path could have affected the accuracy of the nebulizer flow rate. Affected devices returned to…
-
Class II · 25 days ago
Baxter Healthcare Corporation PRO+ MRS Surface FOR Versacare recall: There is an error in the product description on the Unique Device
There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the…
-
Class II · 25 days ago
Baxter Healthcare Corporation PRO+ 36" MRS Surface recall: There is an error in the product description on the Unique Device
There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the…
-
Class I · last month
Baxter Healthcare Corporation Dextrose Injection, USP, 70 %, 2000 mL bags recall: Presence of Particulate Matter: particulate matter identified as stainless
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
-
Class II · last month
Baxter Healthcare Corporation Clindamycin Injection USP in 5% Dextrose recall: CGMP Deviations
CGMP Deviations